| 注册
首页|期刊导航|中国药业|京津冀药学领域基础研究区域格局分析

京津冀药学领域基础研究区域格局分析

陈娟 龙俊羽 张婷 杨楠 刘菲 严舒 欧阳昭连

中国药业2025,Vol.34Issue(16):7-14,8.
中国药业2025,Vol.34Issue(16):7-14,8.DOI:10.3969/j.issn.1006-4931.2025.16.002

京津冀药学领域基础研究区域格局分析

Analysis of Regional Pattern of Basic Research in Pharmaceutical Field in the Beijing-Tianjin-Hebei Region

陈娟 1龙俊羽 2张婷 1杨楠 3刘菲 3严舒 1欧阳昭连1

作者信息

  • 1. 中国医学科学院·北京协和医学院医学信息研究所·图书馆,北京 100020
  • 2. 北京大学医学部,北京 100191
  • 3. 广东省深圳市卫生健康发展研究和数据管理中心,广东 深圳 518028
  • 折叠

摘要

Abstract

Objective To analyze the regional patterns and characteristics of basic research in pharmaceutical field in the Beijing-Tianjin-Hebei region,and to provide references for regional collaboration and scientific policy-making.Methods Based on the Web of Science database,all SCI paper data in pharmaceutical field in the three places from January 1,2020 to February 14,2025 were retrieved,and the differences in research scale and impact,cross-regional cooperation,international cooperation participation,research leadership,leading research institutions and researchers in the three places were analyzed by bibliometric method.Results In terms of research scale and impact,the number of publications in the three places showed a steady upward trend from 2022 to 2025;the research scale of Beijing in pharmaceutical field(17 499 articles)was far more than that of Tianjin(3 881 articles)and Hebei(3 111 articles).The average citation frequency of Beijing and Tianjin was significantly higher than that of Hebei.In terms of cross-regional collaboration,Beijing showed strong autonomy in scientific research,and the proportion of cooperative papers with Tianjin(4.10%)and Hebei(3.27%)was low.Tianjin showed higher dependency on Beijing(18.47%),while Hebei was even more reliant on Beijing(18.90%)and Tianjin(8.23%).In terms of international cooperation participation,the proportion of Beijing-Tianjin-Hebei international cooperation papers was 14.33%,13.22%and 7.71%,respectively.In terms of research leadership,the proportion of corresponding authors from local areas in published papers in Beijing and Tianjin was 71.54%and 70.99%,respectively,which was significantly higher than that in Hebei(63.52%).In terms of leading research institutions and researchers,Beijing possessed numerous high-level research institutions and leading researchers.The institution with the highest number of publications was the affiliated institution of the Chinese Academy of Medical Sciences in Beijing(3 163 articles),with 29 people published≥40 articles.The leading research institutions and researchers in Tianjin were concentrated in the direction of traditional Chinese medicine.The institution with the highest number of publications was Tianjin University of Traditional Chinese Medicine(1 101 articles),with 5 people published≥40 articles;the overall strength of scientific research institutions in Hebei was relatively weak.Most of the leading institutions were concentrated in Shijiazhuang,and there were few leading researchers,with four people published≥20 articles.In terms of research direction,Beijing-Tianjin-Hebei region formed five research directions(drug research and development and mechanism research,tumor treatment and nano-delivery,inflammation and metabolic disease mechanism research,clinical research and evidence-based medicine,nervous system disease model research),three research directions(modernization of traditional Chinese medicine and systematic pharmacology,inflammation and chronic disease mechanism research,tumor treatment and nano-drug delivery system research),three research directions(disease drug intervention and efficacy verification,inflammation and tissue damage mechanism research,tumor mechanism and drug resistance research),respectively.Conclusion There are significant hierarchical differences in basic pharmaceutical research across Beijing-Tianjin-Hebei region,future efforts should focus on building a collaborative regional innovation system,promoting complementary strengths and resource sharing to achieve coordinated development.

关键词

京津冀/基础研究/药学/区域协同/文献计量学

Key words

Beijing-Tianjin-Hebei region/basic research/pharmacy/regional collaboration/bibliometrics

分类

医药卫生

引用本文复制引用

陈娟,龙俊羽,张婷,杨楠,刘菲,严舒,欧阳昭连..京津冀药学领域基础研究区域格局分析[J].中国药业,2025,34(16):7-14,8.

基金项目

北京市社会科学基金项目(重点项目)[24JCB024]. (重点项目)

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文